SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Otros idiomas Shandong Xinhua Pharmaceutical Company Limited

Acciones

719 CNE100000411

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:20 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
5,45 ^HKD	+0,74 %		+3,81 %	-5,71 %

25/04	Shandong Xinhua Pharmaceutical Company Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
11/04	Las cápsulas de cefaclor de la unidad Xinhua Pharma pasan la evaluación reglamentaria	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	11/04
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application	08/04
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit	29/03
Shandong Xinhua Pharmaceutical Proposes New Auditor	29/03
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023	28/03
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Xinhua Pharma's Ibuprofen Gets Registration Approval in China	13/03
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient	28/02
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate	19/01
Shandong Xinhua Pharmaceutical Company Limited Announces Executive Changes	25/12
Shandong Xinhua Pharmaceutical Gets Certificate for Registration of Levamlodiping Besylate Tablets	13/12
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of levamlodiping besylate tablets (2.5mg)	13/12
Respiratory Drug by Xinhua Pharmaceutical Unit Passes Regulatory Evaluation for Generic Drugs in China	04/12
Xinhua Pharmaceutical's Nine-Month Profit Jumps 34%	30/10/23
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Shandong Xinhua Pharmaceutical’s AntiCoagulant Tablets Get Drug Registration Certificate	18/10/23
China Grants Marketing Approval for Shandong Xinhua Pharmaceutical's Uric Acid Medication; Shares Rise 4%	11/10/23
Shandong Xinhua Pharmaceutical Company Limited Announces Approval of Marketing Application for Chemical Raw Material Drugs for Drugsof Febuxostat	10/10/23
Xinhua Pharmaceutical Unit's Clarithromycin Granules Passes Regulatory Evaluation	20/09/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Shandong Xinhua Pharmaceutical Company Limited

Acciones

719

CNE100000411

Otros idiomas

Filtros